Meta Shares Decline Following Quarterly Results Iran Internet Disruptions Weigh on User Growth Novartis Upgrades FullYear Sales and Profit Guidance on Strong Operational Momentum Key Market Movers SpaceX IPO Speculation Nvidia Earnings and Bezos AI Bubble Comments Highlighted in CNBCs Morning Squawk Kevin Warsh Faces HighStakes Fed Role as Constraints Limit Potential Rate Cuts US New Home Sales Slump in April as Higher Mortgage Rates and Prices Weigh on Demand South KoreaNetherlands Chip Alliance Expands Beyond ASML Semiconductor Partnership Biodesix Inc BDSX Q1 2026 Earnings Strong EPS Beat Overshadowed by Negative Stock Reaction SON Q1 2026 Earnings EPS Slightly Misses Estimates Amid Mixed Market Signals First Bank FRBA Q1 2026 Earnings EPS Misses Estimates by a Wide Margin as Profitability Pressures Emerge Agree Realty Q1 2026 Earnings EPS Beats Estimates as Company Delivers Strong Operational Performance MG Q1 2026 Earnings EPS Beats Estimates by 553 as Company Reports Profitability TTAN Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Recurring Revenue Growth Geospace Technologies GEOS Drops 25 as Shares Approach Critical Support at 797 Rezolve AI RZLV Declines 209 Approaching Critical Support at 245 FrontView REIT Inc FVR Slides 15 as Sector Headwinds Weigh on Momentum Verra Mobility VRRM Climbs 09 as Stock Tests Resistance Near 1416 Brenmiller Energy BNRG Holds Steady at 159 as Stock Consolidates Between Key Levels AMG Q1 2026 Earnings EPS Beats Estimates Amid Quiet Revenue Disclosure CBFV Q1 2026 Earnings EPS Beats Estimates Stock Rises on Strong Performance ADGM Q1 2026 Earnings EPS Misses Estimates Shares Slide 108 CRS Q1 2026 Earnings Earnings Beat on Solid Demand Stock Slips Despite Beat NIC Q1 2026 Earnings Significant EPS Miss Despite Positive Stock Reaction Customers Bancorp CUBI Q1 2026 Earnings EPS Beat Highlights Profitability Resilience Wall Street Divided on Paramount Skydance Outlook Amid Industry Uncertainty WGRX Q1 2026 Earnings EPS Loss of 007 Triggers Sharp Decline Travere Therapeutics TVTX Hovers Near Resistance as Slight Dip Tests Support Levels